Company / Free Cash Flow
GRAIL, Inc. Free Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$299.9M
FY2025
5-year range
-$608.7M / -$299.9M
FY2022-FY2025
Trend
+48.5%
vs FY2024
Sector context
#148 of 151
Health Care
What the data says
Among 151 Health Care companies, GRAIL, Inc. is in the bottom 2% for free cash flow. Improved from -$609M to -$300M over the past 2 years.
Based on SEC 10-K filings.
-$300M in FY2025.
Improved from -$609M to -$300M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 151This company -$299.9M Sector average $779.8M
▼
-138.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 48.5% year-over-year.
- Ranks #148 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$299.9M | +48.5% |
| FY2024 | -$582.4M | +4.3% |
| FY2023 | -$608.7M | -4.2% |
| FY2022 | -$584.2M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026